GM-CSF as a therapeutic target in autoimmune diseases.

about

Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?

P2860

Q52665595-8AFECB50-40BC-46BD-BB15-B509CC6B7C8F

P2860

GM-CSF as a therapeutic target in autoimmune diseases.

Item

http://www.wikidata.org/entity/Q47138480

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

GM-CSF as a therapeutic target in autoimmune diseases.

@en

GM-CSF as a therapeutic target in autoimmune diseases.

@nl

type

Item

label

GM-CSF as a therapeutic target in autoimmune diseases.

@en

GM-CSF as a therapeutic target in autoimmune diseases.

@nl

prefLabel

GM-CSF as a therapeutic target in autoimmune diseases.

@en

GM-CSF as a therapeutic target in autoimmune diseases.

@nl

P1476

GM-CSF as a therapeutic target in autoimmune diseases.

@en

P2093

Aoi Shiomi

http://www.w3.org/2001/XMLSchema#string

Takashi Usui

http://www.w3.org/2001/XMLSchema#string

Tsuneyo Mimori

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

CNS immune privilege: hiding in plain sight.

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease

Pivotal roles of GM-CSF in autoimmunity and inflammation

Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines

Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases

Sargramostim for active Crohn's disease

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

P2888

s41232-016-0014-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S41232-016-0014-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017318827

http://www.w3.org/2001/XMLSchema#string

P698

29259681

http://www.w3.org/2001/XMLSchema#string

P932

5725926

http://www.w3.org/2001/XMLSchema#string

GM-CSF as a therapeutic target in autoimmune diseases.

about

P2860

P2860

GM-CSF as a therapeutic target in autoimmune diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932